Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥1,908 | ¥4,218 | ¥5,076 | ¥6,720 |
| Dep. & Amort. | ¥4,332 | ¥3,659 | ¥3,870 | ¥3,313 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥540 | -¥1,174 | -¥2,326 | -¥4,399 |
| Other Non-Cash | ¥197 | -¥1,521 | -¥2,465 | -¥1,264 |
| Operating Cash Flow | ¥5,897 | ¥5,182 | ¥4,155 | ¥4,370 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥7,095 | -¥6,276 | -¥5,556 | -¥4,733 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥68 |
| Inv. Purchases | -¥713 | ¥0 | ¥0 | -¥68 |
| Inv. Sales/Matur. | ¥444 | ¥335 | ¥0 | ¥256 |
| Other Inv. Act. | -¥1 | ¥11 | -¥10 | ¥77 |
| Investing Cash Flow | -¥7,365 | -¥5,930 | -¥5,566 | -¥4,400 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥2,625 | ¥1,971 | ¥1,362 | ¥56 |
| Stock Issued | ¥0 | ¥0 | ¥308 | ¥1,514 |
| Stock Repurch. | -¥623 | -¥1,176 | -¥116 | ¥0 |
| Dividends Paid | -¥998 | -¥907 | -¥931 | -¥660 |
| Other Fin. Act. | -¥2 | -¥71 | -¥7 | ¥79 |
| Financing Cash Flow | ¥1,002 | -¥183 | ¥616 | ¥989 |
| Forex Effect | -¥54 | ¥51 | ¥20 | ¥48 |
| Net Chg. in Cash | -¥520 | -¥880 | -¥774 | ¥1,009 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥2,727 | ¥3,607 | ¥4,381 | ¥3,372 |
| End Cash | ¥2,207 | ¥2,727 | ¥3,607 | ¥4,381 |
| Free Cash Flow | -¥957 | -¥1,094 | -¥1,401 | -¥363 |